Latest filing published 20 Aug 2026 for Charles River Laboratories International, INC., €81k.
Nancy C. Andrews, listed as senior executive, appears in our data through filings on Charles River Laboratories International, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 2 March 2020 to 18 August 2026, the count stands at 10 filings.
Sales make up the whole of the open-market record (1 sale, €141k). Outside the open market, there are 7 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 20 August 2026, reports an option exercise of €81k in Charles River Laboratories International, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations